Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

New evidence on stemming low-value prescribing.

New evidence on stemming low-value prescribing. Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.

Save
Print Download PDF
May 1, 2019
Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.
View more articles from the same authors.

Overprescribing contributes to polypharmacy, antibiotic resistance, and opioid misuse. This commentary discusses strategies to change prescriber behavior such as peer comparisons and opioid overdose letters to prescribers whose patients recently overdosed to drive improvement and reflection.

Save
Print Download PDF
Cite
Citation

New evidence on stemming low-value prescribing. Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.